The XURAMPIC brand, founded in 2014 (Sweden), from 585 sister brands and 17478 competing brands. XURAMPIC is owned by ASTRAZENECA, listed on the stock exchange of London The ISIN, the company's International Securities Identification Number, is GB0009895292. XURAMPIC belongs to the Drug Manufacturers business sector.